Terms: = Liver cancer AND EPAS1, MOP2, 2034, ENSG00000116016, PASD2, HIF2A, Q99814 AND Prognosis
4 results:
1. Life span-associated ferroptosis-related genes identification and validation for hepatocellular carcinoma patients as hepatitis B virus carriers.
Weng W; Zhang D; Li S
J Clin Lab Anal; 2023 Jul; 37(13-14):e24930. PubMed ID: 37461802
[TBL] [Abstract] [Full Text] [Related]
2. Influence of the time interval from diagnosis to treatment on survival for early-stage liver cancer.
Tsai WC; Kung PT; Wang YH; Kuo WY; Li YH
PLoS One; 2018; 13(6):e0199532. PubMed ID: 29933395
[TBL] [Abstract] [Full Text] [Related]
3. Inhibition of poly adenosine diphosphate-ribose polymerase decreases hepatocellular carcinoma growth by modulation of tumor-related gene expression.
Quiles-Perez R; Muñoz-Gámez JA; Ruiz-Extremera A; O'Valle F; Sanjuán-Nuñez L; Martín-Alvarez AB; Martín-Oliva D; Caballero T; Muñoz de Rueda P; León J; Gonzalez R; Muntané J; Oliver FJ; Salmerón J
Hepatology; 2010 Jan; 51(1):255-66. PubMed ID: 20034026
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic significance of HIF-2alpha/epas1 expression in hepatocellular carcinoma.
Bangoura G; Liu ZS; Qian Q; Jiang CQ; Yang GF; Jing S
World J Gastroenterol; 2007 Jun; 13(23):3176-82. PubMed ID: 17589895
[TBL] [Abstract] [Full Text] [Related]
